Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes (Q33876297)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes |
scientific article |
Statements
1 reference
Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes (English)
1 reference
Hagop Kantarjian
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
Farhad Ravandi
1 reference
Gautam Borthakur
1 reference
Jean-Pierre Issa
1 reference
Xuelin Huang
1 reference
Gail Morris
1 reference
Donald Berry
1 reference
Ritva Torma
1 reference
1 January 2010
1 reference
1 reference
51
1 reference
73-78
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference